Papers
2
Total Citations
17
H-Index
2
About
Tommaso Gabbani’s research centers on interventional oncology, with a particular focus on improving the precision and safety of stereotactic body radiation therapy (SBRT) for liver malignancies. His major contributions involve pioneering the use of percutaneous ultrasound-guided fiducial marker placement to enhance tracking accuracy in robotic radiosurgery systems like CyberKnife. In his pilot study (2016, 9 citations), Gabbani demonstrated how different gold marker types and needle gauges affect therapeutic usability, laying groundwork for more reliable tumor targeting. His subsequent comparative trial (2017, 8 citations) systematically evaluated three marker-needle combinations, establishing a practical framework for clinicians to select optimal fiducials based on feasibility and safety. These studies directly address a critical challenge in liver cancer treatment: ensuring that radiation beams precisely hit mobile tumors while sparing healthy tissue. Gabbani’s work has been cited by peers developing image-guided radiotherapy protocols, underscoring its impact on clinical practice. By refining a technical step that is often a bottleneck in SBRT workflows, he has helped make non-invasive liver cancer treatment more accessible and effective. His research exemplifies how meticulous procedural innovation can translate into tangible benefits for patients undergoing complex radiation oncology procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2